Back to announcement
20241015_KLBF_Laporan Informasi dan Fakta Material_31746430.pdf
Other Text extracted KLBFSource file signed link, expires in 15 minutes
Extracted text 4
Page 1
Go To English Page
Nomor Surat 069/CSEC-KF/X-2024
Nama Perusahaan Kalbe Farma Tbk
Kode Emiten KLBF
Lampiran 2
Penyampaian informasi sehubungan dengan Peresmian Pabrik Radioisotop
Perihal
Dalam Negeri
Dengan ini kami untuk dan atas nama perusahaan menyampaikan Laporan Informasi atau Fakta Material sebagai
berikut:
Nama Emiten atau Perusahaan Publik Kalbe Farma Tbk
Bidang Usaha Farmasi
Telepon 42873888
Faksimili 42873680
Alamat Surat Elektronik (email) info@kalbe.co.id
Tanggal Kejadian 15 Oktober 2024
Jenis Informasi atau Fakta Material Penyampaian informasi sehubungan dengan Peresmian
Pabrik Radioisotop Dalam Negeri
Uraian Informasi atau Fakta Material Dalam rangka memenuhi Peraturan Otoritas Jasa Keuangan
No. 31/POJK.04/2015 tanggal
16 Desember 2015 tentang Keterbukaan atas Informasi atau
Fakta Material oleh Emiten atau Perusahaan Publik,
Perusahaan menyampaikan bahwa Perusahaan melalui anak
usahanya, PT Global Onkolab Farma (GOF), meresmikan
pembangunan pabrik radioisotop yang memproduksi
Fluorodeoxyglucose (FGD) untuk keperluan deteksi dini
penyakit kanker.
Dampak kejadian, informasi atau fakta Pabrik Radioisotop yang memproduksi Fluorodeoxyglucose
material tersebut terhadap kegiatan (FGD) ini diharapkan dapat menunjang layanan pemeriksaan
operasional, hukum, kondisi keuangan, Positron Emission Tomography and Computed Tomography
atau kelangsungan usaha Emiten atau Scanning (PET/CT-Scan) yang ada di rumah sakit.
Perusahaan Publik
Hal ini diharapkan dapat memperkuat posisi Perusahaan
terutama pada Segmen Obat Resep.
Demikian untuk diketahui.
Hormat Kami,
Kalbe Farma Tbk
Maria Teresa Fabiola
Corporate Secretary
Page 2
Kalbe Farma Tbk
Gedung KALBE Let.Jend Suprato Kav. 4
Telepon : 42873888
Nama Pengirim Maria Teresa Fabiola
Jabatan Corporate Secretary
Tanggal dan Waktu 15-10-2024 19:46
Lampiran 1. KLBF - Keterbukaan Informasi Radioisotop.pdf
2. KLBF - Disclosure Information Radioisotope.pdf
Dokumen ini merupakan dokumen resmi Kalbe Farma Tbk yang tidak memerlukan tanda tangan karena dihasilkan
secara elektronik oleh sistem pelaporan elektronik. Kalbe Farma Tbk bertanggung jawab penuh atas informasi yang
tertera didalam dokumen ini.
Page 3
Go To Indonesian Page
Letter / Announcement No. 069/CSEC-KF/X-2024
Issuer Name Kalbe Farma Tbk
Issuer Code KLBF
Attachment 2
Subject Submission of information regarding Inauguration Domestic Radioisotope
Production Facility.
The company hereby announce the Material Information or Facts Report as follows
Name of Issuer or Public Company Kalbe Farma Tbk
Business Activities Farmasi
Telephone 42873888
Faximile 42873680
Email Address info@kalbe.co.id
Date of Event 15 October 2024
Submission of information regarding Inauguration Domestic
Type of Material Information or Facts Radioisotope Production Facility.
Description of Material Information or In compliance with Indonesia Financial Services Authority
Facts Regulation No. 31/POJK.04/2015 dated December 16, 2015,
regarding Disclosure of Information or Material Facts by the
Issuer or a Listed Company, the Company hereby announces
that the Company through its subsidiary, PT Global Onkolab
Farma (GOF), inaugurated radioisotope production facility that
produces Fluorodeoxyglucose (FDG) for the early detection of
cancer.
Impact of event, material information or The Radioisotope Factory that produces Fluorodeoxyglucose
facts towards Issuers or Public (FDG) is expected to support the services for Positron
Company’s operational activities, legal, Emission Tomography and Computed Tomography Scanning
financial condition, or going concern (PET/CT-Scan) in hospitals.
This is expected to strengthen the Company's position,
particularly in the Prescription Pharmaceuticals Segment.
Thus to be informed accordingly.
Respectfully,
Kalbe Farma Tbk
Maria Teresa Fabiola
Corporate Secretary
Kalbe Farma Tbk
Gedung KALBE Let.Jend Suprato Kav. 4
Phone : 42873888
Page 4
Sender Name Maria Teresa Fabiola
Function Corporate Secretary
Date and Time 15-10-2024 19:46
Attachment 1. KLBF - Keterbukaan Informasi Radioisotop.pdf
2. KLBF - Disclosure Information Radioisotope.pdf
This is an official document of Kalbe Farma Tbk that does not require a signature as it was generated electronically
by the electronic reporting system. Kalbe Farma Tbk is fully responsible for the information contained within this
document.
Names mentioned 5 people and organisations named in the text · linked when the evidence is strong
unresolved
org
PT Global Onkolab Farma
p.1 ×2
unresolved
person
Maria Teresa Fabiola
· Corporate Secretary
p.1 ×2
unresolved
org
Financial Services Authority
p.3
Extraction attempts how the parser did, and what it refused
Nothing structured was extracted from this document — the attempts below say why.
No extraction attempted yet.